A Single-center, Pilot, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ensifentrine in the Recovery of Hospitalized Patients With COVID-19
This pilot study is being performed to assess the efficacy and safety of inhaled ensifentrine delivered via pMDI compared with a matching placebo in conjunction with standard of care treatments on recovery in patients hospitalized due to COVID-19 infection.
100 Clinical Results associated with Verona Pharma, Inc.
0 Patents (Medical) associated with Verona Pharma, Inc.
100 Deals associated with Verona Pharma, Inc.
100 Translational Medicine associated with Verona Pharma, Inc.